Education
About Us
Working with TipRanks
Follow Us
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (HK:2291)
:2291
RESEARCH TOOLSreports
2291 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$13.28 - HK$33.00
Previous CloseN/A
Volume129.00K
Average Volume (3M)789.85K
Market Cap
HK$9.02B
Enterprise ValueHK$4.73B
Total Cash (Recent Filing)HK$1.13B
Total Debt (Recent Filing)HK$1.51M
Price to Earnings (P/E)33.9
Beta0.60
Next Earnings
Mar 27, 2026EPS EstimateN/A
Last Dividend Ex-Date
May 26, 2025Dividend Yield2.55%
Share Statistics
EPS (TTM)0.57
Shares Outstanding346,750,000
10 Day Avg. Volume490,708
30 Day Avg. Volume789,846
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H News
2291 FAQ
What was LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s price range in the past 12 months?
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H lowest stock price was HK$13.28 and its highest was HK$33.00 in the past 12 months.
What is LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s market cap?
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s market cap is HK$9.02B.
When is LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s upcoming earnings report date?
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s upcoming earnings report date is Mar 27, 2026 which is in 217 days.
How were LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s earnings last quarter?
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H released its earnings results on Aug 22, 2025. The company reported HK$0.571 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.571.
Is LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H overvalued?
According to Wall Street analysts LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s price is currently Overvalued.
Does LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H pay dividends?
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H pays a Annually dividend of HK$0.674 which represents an annual dividend yield of 2.55%. See more information on LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H dividends here
What is LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s EPS estimate?
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H have?
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H has 346,750,000 shares outstanding.
What happened to LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s price movement after its last earnings report?
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H reported an EPS of HK$0.571 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.674%.
Which hedge fund is a major shareholder of LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:2291
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
61.76%
12-Months-Change
Fundamentals
Return on Equity
12.54%
Trailing 12-Months
Asset Growth
1.36%
Trailing 12-Months
Company Description
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding company, engages in the research, development, manufacture, and commercialization of interventional medical devices worldwide. The company offers congenital heart diseases interventional treatment solutions, including atrial septal defect, ventricular septal defect, and patent ductus arteriosus occluder products; delivery systems; and snare products. It also provides cardioembolic stroke prevention solutions, such as left atrial appendage and patent foramen ovale occluder products; treatment of valvular disease solutions comprising aortic valve products, mitral valve products, tricuspid valve products, pulmonary valve products, and procedural accessories; and vascular plugs and interatrial shunt devices. The company offers its products primarily to distributors and hospitals. LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is a subsidiary of Lepu Medical Technology (Beijing) Co., Ltd.
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (2291) Earnings & Revenues
Technical Analysis
MicroPort CardioFlow Medtech Corp.
―
Jiangsu Recbio Technology Co., Ltd. Class H
―
Broncus Holding Corp.
―
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
―
Beauty Farm Medical & Health Industry, Inc.
―
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
99.96% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---